Correlation Between Regeneron Pharmaceuticals and 172967KM2

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and 172967KM2 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and 172967KM2 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and C 625, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and 172967KM2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of 172967KM2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and 172967KM2.

Diversification Opportunities for Regeneron Pharmaceuticals and 172967KM2

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Regeneron and 172967KM2 is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and C 625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 172967KM2 and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with 172967KM2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 172967KM2 has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and 172967KM2 go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and 172967KM2

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the 172967KM2. In addition to that, Regeneron Pharmaceuticals is 1.1 times more volatile than C 625. It trades about -0.29 of its total potential returns per unit of risk. C 625 is currently generating about -0.22 per unit of volatility. If you would invest  10,124  in C 625 on September 4, 2024 and sell it today you would lose (513.00) from holding C 625 or give up 5.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy90.48%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  C 625

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
172967KM2 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C 625 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 172967KM2 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Regeneron Pharmaceuticals and 172967KM2 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and 172967KM2

The main advantage of trading using opposite Regeneron Pharmaceuticals and 172967KM2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, 172967KM2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 172967KM2 will offset losses from the drop in 172967KM2's long position.
The idea behind Regeneron Pharmaceuticals and C 625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like